Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - macrogol 3350, quantity: 525 mg/ml; potassium chloride, quantity: 1.86 mg/ml; sodium bicarbonate, quantity: 7.14 mg/ml; sodium chloride, quantity: 14.03 mg/ml - oral liquid - excipient ingredients: methyl hydroxybenzoate; benzyl alcohol; acesulfame potassium; purified water; sucralose; ethyl hydroxybenzoate; flavour - for use in adults and children over 12 years of age for effective relief from constipation and treatment of chronic constipation. movicol is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of abdomen and rectum in adults and children over 12 years of age.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 100 g; potassium chloride 1 g; sodium chloride 2 g; sodium sulfate 9 g;  ; macrogol 3350 40 g; potassium chloride 1.2 g; sodium chloride 3.2 g; ascorbic acid 7.54 g;  ; sodium ascorbate 48.11 g;   - powder for oral solution - active: macrogol 3350 100 g potassium chloride 1 g sodium chloride 2 g sodium sulfate 9 g   excipient: citric acid mango flavour va93382 sucralose active: macrogol 3350 40 g potassium chloride 1.2 g sodium chloride 3.2 g excipient: aspartame fruit mix flavour (fruit punch) fv654 va93402 active: ascorbic acid 7.54 g   sodium ascorbate 48.11 g   - for bowel cleansing prior to any procedure requiring a clean bowel.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 100 g;  ; potassium chloride 1.015 g; sodium chloride 2.691 g; sodium sulfate 7.5 g;  ; ascorbic acid 4.7 g;  ; sodium ascorbate 5.9 g;   - powder for oral solution - active: macrogol 3350 100 g   potassium chloride 1.015 g sodium chloride 2.691 g sodium sulfate 7.5 g   excipient: acesulfame potassium aspartame lemon flavour v3938-1n1 active: ascorbic acid 4.7 g   sodium ascorbate 5.9 g   - moviprep is used for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g., bowel endoscopy, lower gastrointestinal radiology or digestive tract surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 100 g;  ; potassium chloride 1.015 g; sodium chloride 2.691 g; sodium sulfate 7.5 g;  ; ascorbic acid 4.7 g;  ; sodium ascorbate 5.9 g;   - powder for oral solution - active: macrogol 3350 100 g   potassium chloride 1.015 g sodium chloride 2.691 g sodium sulfate 7.5 g   excipient: acesulfame potassium aspartame orange flavour sn760137 active: ascorbic acid 4.7 g   sodium ascorbate 5.9 g   - moviprep is used for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g., bowel endoscopy, lower gastrointestinal radiology or digestive tract surgery.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - macrogol 13,125 g; potassium chloride 0,0466 g; sodium hydrogen carbonate 0,1785 g; sodium chloride 0,3507 g - powder for oral solution - 13,7 g - macrogol 3350 13.125 g; sodium chloride 0.351 g; potassium chloride 0.047 g; sodium bicarbonate 0.179 g - macrogol, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - potassium chloride, quantity: 600 mg - tablet, modified release - excipient ingredients: macrogol 6000; ethylcellulose; cocoa powder; stearic acid; magnesium stearate; titanium dioxide; hypromellose; triacetin - treatment of all types of potassium deficiencies, particularly hypochloraemic or hypokalaemic alkalosis associated with prolonged or intensive diuretic therapy, eg. in hypertension, cardiac failure or massive oedema (potassium replacement is particularly important to patients receiving digitalis, as the clinical response to this drug is seriously affected by hypokalaemia), in renal disease associated with increased potassium excretion eg. nephrotic syndrome; vomiting and diarrhoea, ulcerative colitis, steatorrhoea, diabetes insipidus, and uncontrolled diabetes mellitus; ileostomy or colostomy patients, cirrhosis; cushing's syndrome and dietary insufficiency; during prolonged or intensive treatment with corticosteroids, acth or carbenoxolone; hyperaldosteronism in megaloblastic anaemia, during the early stages of treatment. here span-k is indicated if a diet rich in potassium cannot be guaranteed.

Malta - English - Medicines Authority

norgine bv antonio vivaldistraat 150, 1083 hp amsterdam, netherlands - macrogol, sodium sulfate, anhydrous, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate - powder for oral solution - sodium ascorbate 5.900 g sodium chloride 2.691 g ascorbic acid 4.700 g sodium sulfate anhydrous 7.500 g macrogol 3350 100 g potassium chloride 1.015 g - drugs for constipation

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - sodium hydrogen carbonate 89,25 mg; macrogol 6562,5 mg; potassium chloride 23,3 mg; sodium chloride 175,35 mg - powder for oral solution - 6,9 g - sodium bicarbonate 89.25 mg; sodium chloride 175.35 mg; potassium chloride 23.3 mg; macrogol 3350 6562.5 mg - macrogol, combinations

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - macrogol 13,125 g; potassium chloride 0,0466 g; sodium chloride 0,3507 g; sodium hydrogen carbonate 0,1785 g - powder for oral solution - 13,125 g - 351 mg - 179 mg - 47 mg - sodium chloride 350.7 mg; sodium bicarbonate 178.5 mg; potassium chloride 46.6 mg; macrogol 3350 13.125 g - macrogol, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

norgine limited - macrogol 3350, sodium chloride ph.eur., sodium bicarbonate, potassium chloride - powder for oral solution - 13.7 grams - osmotically acting laxatives